Tuija Hemmilä


Institute of Dentistry (Institute of Dentistry)

tuija.hemmila@utu.fi
Lemminkäisenkatu 2
Turku





Publications

Voriconazole greatly increases the exposure to oral buprenorphine (2018)
European Journal of Clinical Pharmacology
Mari Fihlman, Tuija Hemmilä, Nora M. Hagelberg, Janne T. Backman, Jouko Laitila, Kari Laine, Pertti J. Neuvonen, Klaus T. Olkkola, Teijo I. Saari
(
A1 Journal article – refereed)

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects (2016)
Pharmacology Research and Perspectives
Hagelberg Nora M, Fihlman M, Hemmilä Tuija, Backman Janne T, Neuvonen Pertti J, Laine Kari, Olkkola Klaus T, Saari Teijo
(
A1 Journal article – refereed)

Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction (2016)
European Journal of Clinical Pharmacology
Fihlman M, Hemmila T, Hagelberg NM, Kuusniemi K, Backman JT, Laitila J, Laine K, Neuvonen PJ, Olkkola KT, Saari TI
(
A1 Journal article – refereed)

Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions (2012)
Pain Practice
Nieminen TH, Hagelberg NM, Saari TI, Gronlund J, Neuvonen PJ, Olkkola KT
(
B1 Journal article)

Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects (2011)
European Journal of Clinical Pharmacology
Hagelberg NM, Nieminen TH, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT
(
A1 Journal article – refereed)


Last updated on 2019-26-08 at 02:21